EuroTimes Satellite Education Programme Information
Thursday 17 May
16.00 - 17.30 Micro Incision Vitrectomy: A Paradigm Shift in Modern Vitreoretinal Surgery Moderator: S. Chang USA Programme: S. Chang USA Shifting to Micro-Incision Vitrectomy Surgery (MIVS) A. Nikolakopoulos GREECE Maximizing patient outcomes with 25G MIVS J. F. Korobelnik FRANCE 25G MIVS: Clinical Results S. Chang USA 23G Vitrectomy: a new option for MIVS M. De Smet NETHERLANDS 23G MIVS: Surgical indications J. García-Arumí SPAIN 23G MIVS: Clinical results Panel Discussion S. Rizzo ITALY Addressing the Art of Wound Construction C. Groenewald UK Comparing 23G to 25G Vitrectomy Surgery Panel Discussion S. Chang USA Conclusion Sponsored by
16.00 - 17.30 Micro Incision Vitrectomy: A Paradigm Shift in Modern Vitreoretinal Surgery
Sponsored by
Friday 18 May
13.00 - 14.00 Future Directions of Macular Edema Moderator: G. Soubrane FRANCE F. Bandello ITALY Programme: Introduction and Welcome W. Drexler UK High Resolution In Vivo Imaging in ME and other retinal diseases A. Augustin GERMANY Pathophysiology of ME, Structure and Function J. Burke USA The anti-inflammatory approach and steroid pharmacokinetics F. Bandello ITALY Treatment algorithms in ME; Mono, Combo or Triple? B. Kupperman USA Ocular Drug Delivery Systems and their Clinical Implications G. Soubrane FRANCE F. Bandello ITALY Sum Up and Close Sponsored by 18.00 Balancing risk in the preservation of visual health Moderator: J.J. De Laey BELGIUM Programme: J.J. De Laey BELGIUM Introduction J.J. Rakic BELGIUM New Perspectives in Pathophysiology of Neovascular AMD Selective VEGF inhibition: Clinical differences in systemic and ocular effects F. Ruschitzka SWITZERLAND Balancing control of systemic VEGF D. Shima UK Challenges in controlling intraocular VEGF G. Staurenghi ITALY New strategies for treating neovascular AMD: The art of balancing benefits and risks Question and Answer Session Conclusions and Close Followed by a reception Sponsored by
13.00 - 14.00 Future Directions of Macular Edema
18.00 Balancing risk in the preservation of visual health
Selective VEGF inhibition: Clinical differences in systemic and ocular effects
F. Ruschitzka SWITZERLAND Balancing control of systemic VEGF D. Shima UK Challenges in controlling intraocular VEGF
F. Ruschitzka SWITZERLAND Balancing control of systemic VEGF
D. Shima UK Challenges in controlling intraocular VEGF
Saturday 19 May
13.00 - 14.00 Looking Forward in Neovascular AMD > Putting Lucentis® into practice Moderator: G. Soubrane FRANCE Programme: G. Soubrane FRANCE Introduction F. Bandello ITALY Lucentis® in clinical practice S. Wolf SWITZERLAND Managing your clinic in the anti-VEGF era: A view on clinic procedures Panel discussion G. Soubrane FRANCE Closing remarks Sponsored by
13.00 - 14.00 Looking Forward in Neovascular AMD > Putting Lucentis® into practice